Related Experiment Video
Updated: Jul 12, 2026

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder
Published on: June 23, 2023
Cardiovascular effects of propranolol in patients with alcohol dependence during withdrawal
Seppo Kähkönen1, Boris Bondarenko, Jari Lipsanen
1BioMag Laboratory, Helsinki University Central Hospital, University of Helsinki, Finland. Seppo.Kahkonen@helsinki.fi
Abstract:
The cardiovascular effects of the beta-adrenergic receptor antagonist propranolol (40 mg) were compared in 20 alcohol-dependent subjects during alcohol withdrawal syndrome (WS; n=10) on days 1, 2, 3, and 10 to those during remission (n=10; 50 +/- 7.7 days). Significant differences were observed in negative chronotropic and hypotensive effects during withdrawal compared to remission. The initial level of hemodynamics prior to propranolol administration was the most important factor modifying the drug responses. The amount of daily consumption of alcohol also predicted to some extent the effects of propranolol. The WS-related changes in peripheral and central beta-adrenergic system were most likely responsible for the differences in propranolol actions.
Related Concept Videos
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
CNS Depressants: Alcohol and Nicotine
Combined Effects of Drugs: Antagonism
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Adrenergic Antagonists: ɑ and β-Receptor Blockers
Antihypertensive Drugs: Types of β-Blockers
